| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Women's Health | 78 | 2023 | 2065 | 3.990 |
Why?
|
| Aspirin | 108 | 2019 | 3133 | 3.960 |
Why?
|
| Fatty Acids, Omega-3 | 44 | 2024 | 1390 | 3.770 |
Why?
|
| Vitamin E | 51 | 2022 | 872 | 3.700 |
Why?
|
| Cardiovascular Diseases | 193 | 2024 | 15500 | 3.590 |
Why?
|
| Dietary Supplements | 80 | 2024 | 3415 | 3.210 |
Why?
|
| Cholecalciferol | 28 | 2024 | 553 | 3.060 |
Why?
|
| Vitamins | 49 | 2023 | 1635 | 3.050 |
Why?
|
| Vitamin D | 53 | 2024 | 3303 | 2.370 |
Why?
|
| Migraine Disorders | 41 | 2023 | 1701 | 2.300 |
Why?
|
| Antioxidants | 39 | 2014 | 1668 | 2.220 |
Why?
|
| Migraine with Aura | 10 | 2022 | 204 | 1.940 |
Why?
|
| Carotenoids | 35 | 2013 | 621 | 1.910 |
Why?
|
| Primary Prevention | 25 | 2020 | 1186 | 1.830 |
Why?
|
| Risk Factors | 386 | 2024 | 74206 | 1.720 |
Why?
|
| beta Carotene | 46 | 2019 | 523 | 1.670 |
Why?
|
| Middle Aged | 603 | 2024 | 220895 | 1.670 |
Why?
|
| Double-Blind Method | 132 | 2024 | 12341 | 1.660 |
Why?
|
| C-Reactive Protein | 59 | 2022 | 3826 | 1.640 |
Why?
|
| Polymorphism, Single Nucleotide | 104 | 2023 | 15936 | 1.550 |
Why?
|
| Prospective Studies | 279 | 2024 | 54425 | 1.490 |
Why?
|
| Macular Degeneration | 13 | 2020 | 1007 | 1.370 |
Why?
|
| Myocardial Infarction | 78 | 2023 | 11460 | 1.370 |
Why?
|
| Randomized Controlled Trials as Topic | 114 | 2020 | 10209 | 1.370 |
Why?
|
| Female | 629 | 2024 | 392644 | 1.340 |
Why?
|
| Genome-Wide Association Study | 70 | 2023 | 12690 | 1.320 |
Why?
|
| Pancreatic Neoplasms | 35 | 2023 | 5368 | 1.320 |
Why?
|
| Stroke | 53 | 2023 | 9757 | 1.300 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 23 | 2015 | 2273 | 1.280 |
Why?
|
| Aged | 392 | 2024 | 169289 | 1.240 |
Why?
|
| Body Mass Index | 91 | 2021 | 12953 | 1.230 |
Why?
|
| Ascorbic Acid | 17 | 2022 | 655 | 1.210 |
Why?
|
| Genetic Predisposition to Disease | 89 | 2023 | 17904 | 1.210 |
Why?
|
| Alcohol Drinking | 48 | 2019 | 4028 | 1.190 |
Why?
|
| Incidence | 125 | 2024 | 21353 | 1.180 |
Why?
|
| Migraine without Aura | 5 | 2020 | 82 | 1.180 |
Why?
|
| Exercise | 40 | 2023 | 5890 | 1.180 |
Why?
|
| Proportional Hazards Models | 109 | 2021 | 12463 | 1.150 |
Why?
|
| Humans | 826 | 2024 | 761504 | 1.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 57 | 2023 | 12148 | 1.140 |
Why?
|
| Fruit | 15 | 2017 | 1160 | 1.140 |
Why?
|
| Neoplasms | 72 | 2023 | 22170 | 1.100 |
Why?
|
| Vegetables | 16 | 2017 | 1195 | 1.100 |
Why?
|
| Diet | 47 | 2023 | 8075 | 1.100 |
Why?
|
| Coronary Disease | 28 | 2021 | 5914 | 1.090 |
Why?
|
| Periodontal Diseases | 4 | 2024 | 451 | 1.070 |
Why?
|
| Risk | 107 | 2021 | 9610 | 1.060 |
Why?
|
| Smoking | 68 | 2021 | 9053 | 1.050 |
Why?
|
| Follow-Up Studies | 154 | 2021 | 39106 | 1.040 |
Why?
|
| Vitamin B 6 | 10 | 2019 | 234 | 1.040 |
Why?
|
| Case-Control Studies | 137 | 2023 | 22176 | 1.030 |
Why?
|
| Cataract | 14 | 2013 | 832 | 1.020 |
Why?
|
| Cohort Studies | 173 | 2024 | 41487 | 0.970 |
Why?
|
| Platelet Aggregation Inhibitors | 22 | 2014 | 2751 | 0.960 |
Why?
|
| Colorectal Neoplasms | 32 | 2020 | 6935 | 0.960 |
Why?
|
| Breast Neoplasms | 66 | 2023 | 21012 | 0.940 |
Why?
|
| Hypertension | 53 | 2020 | 8540 | 0.930 |
Why?
|
| Eicosapentaenoic Acid | 7 | 2021 | 561 | 0.930 |
Why?
|
| Integrative Medicine | 4 | 2019 | 87 | 0.910 |
Why?
|
| Menarche | 11 | 2024 | 532 | 0.900 |
Why?
|
| Genetic Loci | 18 | 2022 | 2632 | 0.850 |
Why?
|
| Cholesterol, HDL | 30 | 2022 | 1814 | 0.810 |
Why?
|
| Risk Reduction Behavior | 11 | 2018 | 1112 | 0.790 |
Why?
|
| Homocysteine | 12 | 2015 | 638 | 0.770 |
Why?
|
| Postmenopause | 31 | 2023 | 2513 | 0.760 |
Why?
|
| Docosahexaenoic Acids | 7 | 2021 | 908 | 0.760 |
Why?
|
| Lipids | 24 | 2022 | 3341 | 0.750 |
Why?
|
| Blood Pressure | 36 | 2020 | 8481 | 0.730 |
Why?
|
| alpha-Tocopherol | 6 | 2019 | 126 | 0.720 |
Why?
|
| Cholesterol, LDL | 25 | 2022 | 2382 | 0.710 |
Why?
|
| Sex Hormone-Binding Globulin | 9 | 2020 | 550 | 0.700 |
Why?
|
| Polymorphism, Genetic | 24 | 2012 | 4243 | 0.680 |
Why?
|
| Gonadal Steroid Hormones | 12 | 2020 | 702 | 0.680 |
Why?
|
| Ovarian Neoplasms | 20 | 2022 | 4876 | 0.670 |
Why?
|
| Risk Assessment | 78 | 2023 | 23995 | 0.660 |
Why?
|
| United States | 164 | 2022 | 72334 | 0.660 |
Why?
|
| Menopause | 21 | 2024 | 1646 | 0.650 |
Why?
|
| Obesity | 46 | 2023 | 12947 | 0.650 |
Why?
|
| Male | 323 | 2024 | 360804 | 0.650 |
Why?
|
| Folic Acid | 14 | 2018 | 1323 | 0.640 |
Why?
|
| Seafood | 5 | 2017 | 393 | 0.630 |
Why?
|
| Cholangiocarcinoma | 6 | 2020 | 552 | 0.610 |
Why?
|
| Bile Duct Neoplasms | 6 | 2019 | 605 | 0.610 |
Why?
|
| Motor Activity | 12 | 2015 | 2715 | 0.600 |
Why?
|
| Receptors, Estrogen | 13 | 2020 | 2208 | 0.590 |
Why?
|
| Intercellular Adhesion Molecule-1 | 15 | 2018 | 1126 | 0.590 |
Why?
|
| Vitamin D Deficiency | 9 | 2024 | 1388 | 0.580 |
Why?
|
| Physicians | 51 | 2022 | 4591 | 0.580 |
Why?
|
| Cerebrovascular Disorders | 13 | 2013 | 1474 | 0.570 |
Why?
|
| Cause of Death | 15 | 2017 | 3683 | 0.570 |
Why?
|
| Cholesterol | 23 | 2022 | 2904 | 0.570 |
Why?
|
| Aging | 21 | 2023 | 8708 | 0.560 |
Why?
|
| Odds Ratio | 51 | 2019 | 9646 | 0.560 |
Why?
|
| Adult | 233 | 2023 | 221177 | 0.550 |
Why?
|
| Aged, 80 and over | 125 | 2021 | 58976 | 0.550 |
Why?
|
| Overweight | 17 | 2023 | 2417 | 0.550 |
Why?
|
| Dietary Fats | 10 | 2019 | 1995 | 0.530 |
Why?
|
| Diet Surveys | 8 | 2014 | 1162 | 0.530 |
Why?
|
| Lipoproteins | 7 | 2020 | 881 | 0.520 |
Why?
|
| Vitamin B 12 | 9 | 2019 | 524 | 0.520 |
Why?
|
| Anticarcinogenic Agents | 5 | 2012 | 250 | 0.510 |
Why?
|
| Cyclooxygenase Inhibitors | 6 | 2008 | 361 | 0.510 |
Why?
|
| Coffee | 8 | 2019 | 593 | 0.510 |
Why?
|
| Diabetes Mellitus | 16 | 2024 | 5840 | 0.500 |
Why?
|
| Triglycerides | 18 | 2022 | 2461 | 0.500 |
Why?
|
| Multivariate Analysis | 56 | 2017 | 12059 | 0.500 |
Why?
|
| Amino Acids, Branched-Chain | 4 | 2022 | 269 | 0.500 |
Why?
|
| Weight Gain | 7 | 2020 | 2348 | 0.490 |
Why?
|
| Telomere | 5 | 2017 | 943 | 0.490 |
Why?
|
| Osteoporosis | 2 | 2024 | 1606 | 0.480 |
Why?
|
| Fatty Acids, Omega-6 | 4 | 2020 | 225 | 0.480 |
Why?
|
| Fibrinogen | 10 | 2018 | 888 | 0.480 |
Why?
|
| Intracranial Hemorrhages | 4 | 2019 | 822 | 0.470 |
Why?
|
| Feeding Behavior | 17 | 2013 | 3188 | 0.470 |
Why?
|
| Low Back Pain | 4 | 2018 | 984 | 0.470 |
Why?
|
| Connective Tissue Diseases | 4 | 2010 | 285 | 0.460 |
Why?
|
| Calcium, Dietary | 6 | 2017 | 529 | 0.460 |
Why?
|
| Liver Neoplasms | 10 | 2021 | 4320 | 0.460 |
Why?
|
| Interleukin-6 | 15 | 2020 | 3208 | 0.460 |
Why?
|
| Patient Selection | 11 | 2016 | 4244 | 0.450 |
Why?
|
| Genotype | 50 | 2021 | 12990 | 0.450 |
Why?
|
| Tai Ji | 4 | 2014 | 289 | 0.450 |
Why?
|
| Endometrial Neoplasms | 11 | 2021 | 1366 | 0.450 |
Why?
|
| Dry Eye Syndromes | 7 | 2022 | 387 | 0.450 |
Why?
|
| Brain Ischemia | 16 | 2020 | 3049 | 0.450 |
Why?
|
| Actigraphy | 1 | 2017 | 520 | 0.450 |
Why?
|
| Acupuncture Therapy | 7 | 2016 | 486 | 0.440 |
Why?
|
| Food Analysis | 2 | 2012 | 103 | 0.440 |
Why?
|
| Breast Implants | 4 | 2010 | 411 | 0.440 |
Why?
|
| Alleles | 25 | 2022 | 6863 | 0.420 |
Why?
|
| Endometriosis | 5 | 2023 | 870 | 0.420 |
Why?
|
| Ovary | 4 | 2021 | 959 | 0.410 |
Why?
|
| Gene Frequency | 20 | 2022 | 3606 | 0.400 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2017 | 1934 | 0.400 |
Why?
|
| Life Style | 21 | 2022 | 3917 | 0.400 |
Why?
|
| Reproduction | 4 | 2023 | 645 | 0.400 |
Why?
|
| Fasting | 10 | 2020 | 1603 | 0.400 |
Why?
|
| Estrogen Replacement Therapy | 15 | 2011 | 1208 | 0.400 |
Why?
|
| Inflammation | 23 | 2022 | 10773 | 0.390 |
Why?
|
| Atrial Fibrillation | 13 | 2022 | 5127 | 0.390 |
Why?
|
| Bone Density | 9 | 2023 | 3551 | 0.390 |
Why?
|
| Health Personnel | 12 | 2014 | 3335 | 0.390 |
Why?
|
| Adenocarcinoma | 12 | 2024 | 6346 | 0.380 |
Why?
|
| Epidemiologic Methods | 10 | 2011 | 1336 | 0.380 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 6 | 2010 | 276 | 0.380 |
Why?
|
| Calcium | 5 | 2023 | 5722 | 0.380 |
Why?
|
| Carcinoma, Pancreatic Ductal | 6 | 2021 | 1727 | 0.380 |
Why?
|
| Vitamin B Complex | 5 | 2017 | 299 | 0.380 |
Why?
|
| Telomerase | 6 | 2019 | 745 | 0.380 |
Why?
|
| Age Factors | 40 | 2021 | 18395 | 0.370 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2012 | 396 | 0.370 |
Why?
|
| Carcinoma, Hepatocellular | 6 | 2020 | 2298 | 0.360 |
Why?
|
| Linkage Disequilibrium | 18 | 2022 | 1998 | 0.360 |
Why?
|
| Clinical Trials as Topic | 19 | 2024 | 8002 | 0.360 |
Why?
|
| Contraceptives, Oral | 6 | 2019 | 554 | 0.360 |
Why?
|
| Mortality | 11 | 2021 | 2901 | 0.360 |
Why?
|
| Cognition Disorders | 12 | 2013 | 3979 | 0.350 |
Why?
|
| Waist Circumference | 8 | 2019 | 935 | 0.350 |
Why?
|
| Sex Factors | 31 | 2022 | 10552 | 0.350 |
Why?
|
| Logistic Models | 46 | 2018 | 13255 | 0.350 |
Why?
|
| Parity | 6 | 2024 | 927 | 0.350 |
Why?
|
| Hyperlipidemias | 9 | 2022 | 771 | 0.340 |
Why?
|
| Depression | 10 | 2023 | 8124 | 0.340 |
Why?
|
| Dairy Products | 6 | 2017 | 490 | 0.340 |
Why?
|
| Magnesium | 7 | 2009 | 804 | 0.340 |
Why?
|
| Epidemiology | 2 | 2008 | 279 | 0.340 |
Why?
|
| Dietary Fiber | 5 | 2015 | 759 | 0.330 |
Why?
|
| Restless Legs Syndrome | 4 | 2013 | 233 | 0.330 |
Why?
|
| Placebos | 16 | 2019 | 1667 | 0.330 |
Why?
|
| Meta-Analysis as Topic | 9 | 2017 | 1380 | 0.330 |
Why?
|
| Prostatic Neoplasms | 17 | 2016 | 11118 | 0.330 |
Why?
|
| Tea | 6 | 2018 | 288 | 0.330 |
Why?
|
| Dehydroepiandrosterone Sulfate | 3 | 2018 | 241 | 0.330 |
Why?
|
| Genetic Variation | 18 | 2018 | 6567 | 0.330 |
Why?
|
| Europe | 18 | 2022 | 3422 | 0.330 |
Why?
|
| Body Height | 8 | 2022 | 1570 | 0.330 |
Why?
|
| Receptors, Progesterone | 8 | 2013 | 1129 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 5 | 4 | 2016 | 386 | 0.320 |
Why?
|
| Caffeine | 5 | 2018 | 700 | 0.320 |
Why?
|
| Polysaccharides | 4 | 2016 | 1014 | 0.320 |
Why?
|
| Visual Acuity | 12 | 2015 | 2672 | 0.320 |
Why?
|
| Cross-Sectional Studies | 47 | 2023 | 26125 | 0.310 |
Why?
|
| Carcinoma, Large Cell | 2 | 2019 | 113 | 0.310 |
Why?
|
| Quantitative Trait Loci | 9 | 2022 | 2116 | 0.310 |
Why?
|
| Research Design | 23 | 2016 | 6180 | 0.310 |
Why?
|
| Comorbidity | 25 | 2023 | 10508 | 0.310 |
Why?
|
| Complementary Therapies | 3 | 2019 | 486 | 0.310 |
Why?
|
| Drug Administration Schedule | 13 | 2016 | 4853 | 0.310 |
Why?
|
| Research Support as Topic | 3 | 2008 | 697 | 0.310 |
Why?
|
| Apolipoprotein A-I | 7 | 2020 | 299 | 0.300 |
Why?
|
| Health Behavior | 9 | 2018 | 2643 | 0.300 |
Why?
|
| Eggs | 3 | 2021 | 182 | 0.300 |
Why?
|
| Education, Public Health Professional | 1 | 2008 | 27 | 0.300 |
Why?
|
| Venous Thrombosis | 2 | 2007 | 1303 | 0.300 |
Why?
|
| Biliary Tract Neoplasms | 2 | 2020 | 185 | 0.290 |
Why?
|
| Anthropometry | 7 | 2019 | 1349 | 0.290 |
Why?
|
| Headache | 5 | 2020 | 1256 | 0.290 |
Why?
|
| Fragaria | 1 | 2007 | 21 | 0.290 |
Why?
|
| Urinary Incontinence | 2 | 2022 | 489 | 0.290 |
Why?
|
| Lung Neoplasms | 19 | 2021 | 13380 | 0.290 |
Why?
|
| Fractures, Bone | 5 | 2024 | 2046 | 0.290 |
Why?
|
| Education, Graduate | 1 | 2008 | 75 | 0.290 |
Why?
|
| Mendelian Randomization Analysis | 7 | 2023 | 1007 | 0.290 |
Why?
|
| Flavonoids | 3 | 2009 | 445 | 0.290 |
Why?
|
| Diabetes Complications | 10 | 2020 | 1315 | 0.280 |
Why?
|
| Mosaicism | 3 | 2016 | 475 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2016 | 638 | 0.280 |
Why?
|
| Vitamin A | 5 | 2017 | 613 | 0.280 |
Why?
|
| Physical Fitness | 3 | 2004 | 743 | 0.280 |
Why?
|
| Leukocytes | 4 | 2017 | 2026 | 0.280 |
Why?
|
| Gallbladder Neoplasms | 2 | 2019 | 189 | 0.270 |
Why?
|
| Cataract Extraction | 6 | 2010 | 467 | 0.270 |
Why?
|
| Contraceptives, Oral, Hormonal | 2 | 2020 | 190 | 0.270 |
Why?
|
| Models, Cardiovascular | 3 | 2020 | 981 | 0.270 |
Why?
|
| Stress, Psychological | 6 | 2019 | 4481 | 0.260 |
Why?
|
| Carcinoma, Renal Cell | 7 | 2019 | 3164 | 0.260 |
Why?
|
| Haplotypes | 16 | 2022 | 2713 | 0.260 |
Why?
|
| Time Factors | 36 | 2020 | 39967 | 0.260 |
Why?
|
| Peptidyl-Dipeptidase A | 5 | 2010 | 362 | 0.250 |
Why?
|
| Gout | 2 | 2023 | 621 | 0.250 |
Why?
|
| Treatment Outcome | 38 | 2022 | 64680 | 0.250 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2019 | 251 | 0.240 |
Why?
|
| Fish Oils | 3 | 2021 | 483 | 0.240 |
Why?
|
| Body Size | 4 | 2017 | 463 | 0.240 |
Why?
|
| Drug Combinations | 7 | 2016 | 2048 | 0.240 |
Why?
|
| Lipoprotein(a) | 4 | 2013 | 480 | 0.240 |
Why?
|
| Estrogens, Conjugated (USP) | 4 | 2006 | 276 | 0.240 |
Why?
|
| Colonic Polyps | 2 | 2020 | 554 | 0.240 |
Why?
|
| Factor V | 3 | 2007 | 167 | 0.240 |
Why?
|
| Glomerular Filtration Rate | 9 | 2024 | 2176 | 0.240 |
Why?
|
| Resistance Training | 2 | 2017 | 193 | 0.240 |
Why?
|
| ABO Blood-Group System | 4 | 2013 | 380 | 0.240 |
Why?
|
| Membrane Proteins | 9 | 2021 | 7856 | 0.240 |
Why?
|
| Confidence Intervals | 15 | 2019 | 2927 | 0.240 |
Why?
|
| Testosterone | 7 | 2018 | 2472 | 0.240 |
Why?
|
| Chromosomes, Human, X | 3 | 2016 | 321 | 0.230 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 4 | 2011 | 416 | 0.230 |
Why?
|
| Bile Ducts, Intrahepatic | 4 | 2020 | 296 | 0.220 |
Why?
|
| Kidney Neoplasms | 8 | 2019 | 4249 | 0.220 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2019 | 1116 | 0.220 |
Why?
|
| Glycoproteins | 4 | 2016 | 2203 | 0.220 |
Why?
|
| Receptors, Calcitriol | 3 | 2012 | 360 | 0.220 |
Why?
|
| Predictive Value of Tests | 27 | 2020 | 15266 | 0.220 |
Why?
|
| Xanthophylls | 4 | 2012 | 94 | 0.220 |
Why?
|
| Insulin Resistance | 9 | 2021 | 3963 | 0.220 |
Why?
|
| Uterine Neoplasms | 4 | 2019 | 1420 | 0.220 |
Why?
|
| Affect | 2 | 2021 | 1486 | 0.220 |
Why?
|
| Lipoproteins, LDL | 5 | 2013 | 642 | 0.210 |
Why?
|
| Reproductive History | 3 | 2020 | 211 | 0.210 |
Why?
|
| Diabetic Nephropathies | 2 | 2022 | 973 | 0.210 |
Why?
|
| Fibrinolytic Agents | 3 | 2009 | 2084 | 0.210 |
Why?
|
| Lutein | 4 | 2012 | 123 | 0.210 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2008 | 574 | 0.210 |
Why?
|
| Fertility | 3 | 2023 | 771 | 0.210 |
Why?
|
| Preventive Medicine | 2 | 1994 | 246 | 0.210 |
Why?
|
| Age Distribution | 8 | 2014 | 2880 | 0.210 |
Why?
|
| Lipid Metabolism | 4 | 2021 | 1902 | 0.200 |
Why?
|
| Data Collection | 5 | 2010 | 3322 | 0.200 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2017 | 487 | 0.200 |
Why?
|
| Leptin | 2 | 2023 | 1597 | 0.200 |
Why?
|
| Helicobacter pylori | 2 | 2023 | 377 | 0.200 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2019 | 344 | 0.200 |
Why?
|
| Energy Intake | 10 | 2016 | 2134 | 0.200 |
Why?
|
| Colonic Neoplasms | 7 | 2021 | 2538 | 0.200 |
Why?
|
| Self Report | 5 | 2024 | 3724 | 0.200 |
Why?
|
| Income | 5 | 2019 | 1877 | 0.200 |
Why?
|
| Chromosome Mapping | 4 | 2022 | 4615 | 0.200 |
Why?
|
| Women | 3 | 2012 | 223 | 0.200 |
Why?
|
| Estradiol | 7 | 2015 | 1937 | 0.200 |
Why?
|
| Medication Adherence | 2 | 2019 | 2176 | 0.200 |
Why?
|
| Receptors, Androgen | 5 | 2009 | 1079 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2021 | 313 | 0.190 |
Why?
|
| Lipoproteins, HDL | 4 | 2010 | 676 | 0.190 |
Why?
|
| Editorial Policies | 1 | 2006 | 458 | 0.190 |
Why?
|
| Leiomyoma | 2 | 2019 | 636 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2019 | 4026 | 0.190 |
Why?
|
| Cerebral Hemorrhage | 7 | 2005 | 2656 | 0.190 |
Why?
|
| Genome, Human | 8 | 2022 | 4425 | 0.190 |
Why?
|
| Carbon | 2 | 2017 | 666 | 0.190 |
Why?
|
| Diet, Mediterranean | 2 | 2022 | 740 | 0.190 |
Why?
|
| PPAR alpha | 1 | 2022 | 175 | 0.190 |
Why?
|
| Conflict of Interest | 1 | 2006 | 554 | 0.190 |
Why?
|
| Chemoprevention | 3 | 2012 | 326 | 0.190 |
Why?
|
| Leukoaraiosis | 1 | 2022 | 116 | 0.190 |
Why?
|
| Adiponectin | 3 | 2023 | 1113 | 0.190 |
Why?
|
| Androgens | 4 | 2017 | 1286 | 0.190 |
Why?
|
| Pregnancy Complications | 3 | 2021 | 2947 | 0.190 |
Why?
|
| Cotinine | 2 | 2018 | 206 | 0.190 |
Why?
|
| Thromboembolism | 1 | 2007 | 995 | 0.180 |
Why?
|
| Myocardial Revascularization | 5 | 2020 | 790 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2016 | 452 | 0.180 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2022 | 115 | 0.180 |
Why?
|
| Hypertriglyceridemia | 2 | 2022 | 293 | 0.180 |
Why?
|
| Estrogen Receptor beta | 3 | 2020 | 168 | 0.180 |
Why?
|
| Apolipoproteins B | 4 | 2017 | 386 | 0.180 |
Why?
|
| Inflammation Mediators | 4 | 2018 | 1886 | 0.180 |
Why?
|
| Acute-Phase Proteins | 3 | 2016 | 250 | 0.180 |
Why?
|
| Kynurenine | 2 | 2019 | 141 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2023 | 3245 | 0.170 |
Why?
|
| Prevalence | 21 | 2023 | 15732 | 0.170 |
Why?
|
| Body Composition | 2 | 2021 | 2426 | 0.170 |
Why?
|
| Receptors, Leptin | 2 | 2023 | 350 | 0.170 |
Why?
|
| Meat | 3 | 2008 | 584 | 0.170 |
Why?
|
| Fatty Acids | 3 | 2015 | 1808 | 0.170 |
Why?
|
| Statistics as Topic | 7 | 2011 | 2358 | 0.170 |
Why?
|
| Arthritis, Rheumatoid | 7 | 2010 | 3763 | 0.170 |
Why?
|
| Nutrition Surveys | 4 | 2024 | 1733 | 0.170 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 388 | 0.170 |
Why?
|
| Renin-Angiotensin System | 3 | 2008 | 737 | 0.170 |
Why?
|
| Thrombophlebitis | 3 | 1997 | 289 | 0.160 |
Why?
|
| Cognition | 7 | 2013 | 6990 | 0.160 |
Why?
|
| Ischemic Attack, Transient | 3 | 2014 | 882 | 0.160 |
Why?
|
| Vision Screening | 1 | 2000 | 72 | 0.160 |
Why?
|
| Asthma | 5 | 2016 | 6234 | 0.160 |
Why?
|
| Prolactin | 1 | 2021 | 625 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 2 | 2011 | 127 | 0.160 |
Why?
|
| Ovulation | 1 | 2020 | 181 | 0.160 |
Why?
|
| Adenoma | 2 | 2020 | 2160 | 0.160 |
Why?
|
| Phenotype | 18 | 2022 | 16591 | 0.160 |
Why?
|
| Genetic Association Studies | 6 | 2019 | 2735 | 0.160 |
Why?
|
| Linear Models | 12 | 2018 | 5871 | 0.160 |
Why?
|
| Epidemiologic Studies | 4 | 2013 | 675 | 0.160 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 2 | 2010 | 56 | 0.160 |
Why?
|
| Heart Failure | 4 | 2022 | 11669 | 0.160 |
Why?
|
| Accidental Falls | 2 | 2020 | 1068 | 0.160 |
Why?
|
| Plasma | 2 | 2020 | 586 | 0.160 |
Why?
|
| Nuts | 1 | 2021 | 264 | 0.160 |
Why?
|
| Health Surveys | 11 | 2019 | 4061 | 0.150 |
Why?
|
| Occupational Diseases | 3 | 1995 | 1490 | 0.150 |
Why?
|
| Alcoholic Beverages | 2 | 2005 | 264 | 0.150 |
Why?
|
| Deglutition Disorders | 2 | 2016 | 625 | 0.150 |
Why?
|
| Estrogens | 7 | 2007 | 1522 | 0.150 |
Why?
|
| Hyperglycemia | 2 | 2020 | 1376 | 0.150 |
Why?
|
| Oral Health | 1 | 2024 | 492 | 0.150 |
Why?
|
| Apolipoproteins | 6 | 2008 | 326 | 0.150 |
Why?
|
| Depressive Disorder | 2 | 2021 | 3728 | 0.150 |
Why?
|
| Parkinson Disease | 5 | 2013 | 2877 | 0.150 |
Why?
|
| Erythrocytes | 3 | 2015 | 2413 | 0.150 |
Why?
|
| Hypolipidemic Agents | 1 | 2022 | 609 | 0.150 |
Why?
|
| Carcinoma | 4 | 2016 | 2330 | 0.150 |
Why?
|
| Patient Compliance | 9 | 2012 | 2690 | 0.150 |
Why?
|
| Glioma | 4 | 2015 | 3455 | 0.150 |
Why?
|
| Premenopause | 5 | 2021 | 1039 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 10 | 2016 | 6075 | 0.150 |
Why?
|
| Hypoglycemic Agents | 2 | 2020 | 3085 | 0.150 |
Why?
|
| Methionine | 3 | 2018 | 572 | 0.150 |
Why?
|
| Socioeconomic Factors | 9 | 2019 | 7827 | 0.150 |
Why?
|
| Metabolism | 1 | 2019 | 193 | 0.150 |
Why?
|
| Health Status | 5 | 2019 | 4077 | 0.150 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2009 | 215 | 0.140 |
Why?
|
| Acupuncture | 2 | 2008 | 90 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2018 | 1469 | 0.140 |
Why?
|
| Genetic Markers | 5 | 2019 | 2601 | 0.140 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2012 | 409 | 0.140 |
Why?
|
| Activin Receptors, Type II | 1 | 2017 | 123 | 0.140 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 372 | 0.140 |
Why?
|
| Waist-Hip Ratio | 5 | 2019 | 518 | 0.140 |
Why?
|
| Thyroid Neoplasms | 2 | 2024 | 2332 | 0.140 |
Why?
|
| Menopause, Premature | 2 | 2021 | 124 | 0.140 |
Why?
|
| Tuna | 1 | 2016 | 18 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 8547 | 0.140 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 1996 | 61 | 0.140 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2018 | 131 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 27 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type III | 3 | 2009 | 705 | 0.140 |
Why?
|
| Clinical Protocols | 4 | 2016 | 1440 | 0.140 |
Why?
|
| Neoplasm Metastasis | 3 | 2020 | 4915 | 0.140 |
Why?
|
| Puberty | 2 | 2017 | 501 | 0.140 |
Why?
|
| Adiposity | 4 | 2021 | 1878 | 0.140 |
Why?
|
| Academic Medical Centers | 3 | 2016 | 2759 | 0.140 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2003 | 1033 | 0.140 |
Why?
|
| Reproducibility of Results | 18 | 2021 | 20098 | 0.140 |
Why?
|
| Vascular Diseases | 3 | 2016 | 1161 | 0.140 |
Why?
|
| Recurrence | 8 | 2020 | 8465 | 0.140 |
Why?
|
| Anticoagulants | 1 | 2012 | 4812 | 0.140 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 174 | 0.140 |
Why?
|
| Eating | 3 | 2013 | 1539 | 0.140 |
Why?
|
| Carcinoma, Small Cell | 1 | 2019 | 420 | 0.130 |
Why?
|
| Birth Order | 1 | 2016 | 95 | 0.130 |
Why?
|
| Acetylgalactosamine | 1 | 2016 | 38 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2024 | 1010 | 0.130 |
Why?
|
| Leukoencephalopathies | 1 | 2019 | 256 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2021 | 10766 | 0.130 |
Why?
|
| Hormones | 1 | 2020 | 869 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 3 | 2016 | 2895 | 0.130 |
Why?
|
| Sex Distribution | 8 | 2010 | 2281 | 0.130 |
Why?
|
| Chi-Square Distribution | 9 | 2011 | 3416 | 0.130 |
Why?
|
| Prognosis | 23 | 2023 | 29625 | 0.130 |
Why?
|
| Atherosclerosis | 4 | 2019 | 3408 | 0.130 |
Why?
|
| Systole | 6 | 2018 | 936 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 2 | 2009 | 597 | 0.130 |
Why?
|
| Cardiovascular System | 2 | 2022 | 834 | 0.130 |
Why?
|
| Medical Records | 5 | 2009 | 1408 | 0.130 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2009 | 293 | 0.130 |
Why?
|
| Walking | 5 | 2018 | 1198 | 0.130 |
Why?
|
| Coitus | 1 | 2016 | 132 | 0.130 |
Why?
|
| Calcium Channel Blockers | 2 | 1996 | 694 | 0.130 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 1995 | 56 | 0.130 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 4761 | 0.130 |
Why?
|
| Treatment Failure | 5 | 2021 | 2645 | 0.120 |
Why?
|
| Apolipoprotein B-100 | 2 | 2016 | 157 | 0.120 |
Why?
|
| Receptors, Neurokinin-3 | 1 | 2015 | 59 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 1651 | 0.120 |
Why?
|
| Coronary Artery Disease | 5 | 2019 | 6403 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 8 | 2019 | 3595 | 0.120 |
Why?
|
| Drug Therapy, Combination | 8 | 2021 | 6310 | 0.120 |
Why?
|
| Periodicals as Topic | 1 | 2006 | 1463 | 0.120 |
Why?
|
| Glycemic Index | 3 | 2008 | 396 | 0.120 |
Why?
|
| Dietary Sucrose | 2 | 2010 | 243 | 0.120 |
Why?
|
| Occupations | 4 | 2005 | 515 | 0.120 |
Why?
|
| Nutritional Status | 4 | 2017 | 1615 | 0.120 |
Why?
|
| Diastole | 5 | 2018 | 782 | 0.120 |
Why?
|
| Glass | 1 | 1995 | 115 | 0.120 |
Why?
|
| Back Pain | 1 | 2019 | 545 | 0.120 |
Why?
|
| Phospholipids | 1 | 1999 | 786 | 0.120 |
Why?
|
| Pulmonary Embolism | 3 | 2007 | 2567 | 0.120 |
Why?
|
| Eligibility Determination | 1 | 1998 | 421 | 0.120 |
Why?
|
| Body Weight | 5 | 2020 | 4618 | 0.120 |
Why?
|
| Acetylglucosamine | 1 | 2016 | 189 | 0.120 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 423 | 0.120 |
Why?
|
| DNA Repair | 2 | 2015 | 2045 | 0.120 |
Why?
|
| Medical History Taking | 1 | 2018 | 774 | 0.120 |
Why?
|
| Young Adult | 24 | 2021 | 59243 | 0.120 |
Why?
|
| Activities of Daily Living | 4 | 2023 | 2421 | 0.120 |
Why?
|
| Estradiol Dehydrogenases | 2 | 2010 | 16 | 0.120 |
Why?
|
| Ethanol | 4 | 2015 | 1324 | 0.120 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 227 | 0.110 |
Why?
|
| Observer Variation | 3 | 2003 | 2606 | 0.110 |
Why?
|
| Free Radical Scavengers | 1 | 1995 | 211 | 0.110 |
Why?
|
| Venous Thromboembolism | 3 | 2013 | 1866 | 0.110 |
Why?
|
| Longitudinal Studies | 14 | 2019 | 14605 | 0.110 |
Why?
|
| Laminin | 1 | 2015 | 408 | 0.110 |
Why?
|
| alpha-Linolenic Acid | 1 | 2014 | 144 | 0.110 |
Why?
|
| North America | 7 | 2016 | 1276 | 0.110 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 835 | 0.110 |
Why?
|
| Databases, Genetic | 5 | 2020 | 1742 | 0.110 |
Why?
|
| Absorptiometry, Photon | 5 | 2020 | 1738 | 0.110 |
Why?
|
| Depression, Postpartum | 1 | 2018 | 346 | 0.110 |
Why?
|
| Employment | 2 | 2012 | 1118 | 0.110 |
Why?
|
| Kidney Diseases | 5 | 2009 | 2091 | 0.110 |
Why?
|
| Sex Characteristics | 6 | 2022 | 2639 | 0.110 |
Why?
|
| Adolescent | 28 | 2021 | 88319 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2014 | 3769 | 0.110 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2011 | 190 | 0.110 |
Why?
|
| Proteins | 5 | 2018 | 6032 | 0.110 |
Why?
|
| Death Certificates | 2 | 2021 | 167 | 0.110 |
Why?
|
| Behavior | 1 | 2016 | 541 | 0.110 |
Why?
|
| Iron | 1 | 2021 | 1793 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 9 | 3 | 2009 | 535 | 0.110 |
Why?
|
| Vasculitis | 2 | 2011 | 521 | 0.110 |
Why?
|
| Multiple Myeloma | 3 | 2018 | 5146 | 0.110 |
Why?
|
| Hypercholesterolemia | 9 | 2015 | 1141 | 0.100 |
Why?
|
| Recovery of Function | 3 | 2014 | 2979 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 840 | 0.100 |
Why?
|
| Disease Progression | 13 | 2020 | 13506 | 0.100 |
Why?
|
| Platelet Aggregation | 1 | 1996 | 771 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2000 | 3205 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 789 | 0.100 |
Why?
|
| Sleep Deprivation | 1 | 2019 | 846 | 0.100 |
Why?
|
| Antihypertensive Agents | 5 | 2015 | 2024 | 0.100 |
Why?
|
| Educational Status | 7 | 2015 | 2522 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 68 | 0.100 |
Why?
|
| Men's Health | 1 | 2012 | 73 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1076 | 0.100 |
Why?
|
| Australia | 4 | 2018 | 1250 | 0.100 |
Why?
|
| Headache Disorders | 1 | 2015 | 152 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 7 | 2016 | 751 | 0.100 |
Why?
|
| Obesity, Abdominal | 1 | 2015 | 374 | 0.100 |
Why?
|
| Patient Admission | 1 | 2019 | 1367 | 0.100 |
Why?
|
| Immunoglobulins | 1 | 2015 | 853 | 0.100 |
Why?
|
| Fishes | 2 | 2017 | 603 | 0.100 |
Why?
|
| Cardiology | 1 | 2023 | 1656 | 0.100 |
Why?
|
| Apolipoprotein A-II | 1 | 1992 | 41 | 0.100 |
Why?
|
| Interdisciplinary Communication | 2 | 2008 | 931 | 0.100 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2020 | 1723 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 598 | 0.100 |
Why?
|
| Regression Analysis | 10 | 2013 | 6343 | 0.100 |
Why?
|
| Knee Joint | 1 | 2020 | 1676 | 0.100 |
Why?
|
| Carbonated Beverages | 2 | 2010 | 210 | 0.100 |
Why?
|
| Secondary Prevention | 2 | 2009 | 1475 | 0.100 |
Why?
|
| Cholesterol, Dietary | 2 | 2008 | 224 | 0.100 |
Why?
|
| Registries | 3 | 2020 | 8224 | 0.100 |
Why?
|
| Principal Component Analysis | 2 | 2012 | 943 | 0.090 |
Why?
|
| Angiotensinogen | 2 | 2008 | 161 | 0.090 |
Why?
|
| Asia | 3 | 2018 | 619 | 0.090 |
Why?
|
| Dermatitis, Occupational | 1 | 1991 | 26 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2011 | 540 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2014 | 9606 | 0.090 |
Why?
|
| Paper | 1 | 1991 | 84 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2015 | 1768 | 0.090 |
Why?
|
| Autoantigens | 1 | 2015 | 891 | 0.090 |
Why?
|
| Bone Neoplasms | 2 | 2015 | 2529 | 0.090 |
Why?
|
| Primary Ovarian Insufficiency | 3 | 2021 | 107 | 0.090 |
Why?
|
| Placebo Effect | 3 | 2019 | 518 | 0.090 |
Why?
|
| Random Allocation | 10 | 2001 | 2395 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 3617 | 0.090 |
Why?
|
| Hydro-Lyases | 1 | 2010 | 94 | 0.090 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 133 | 0.090 |
Why?
|
| Boston | 13 | 2011 | 9326 | 0.090 |
Why?
|
| Hyperinsulinism | 2 | 2004 | 400 | 0.090 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2010 | 28 | 0.090 |
Why?
|
| Hemorrhage | 6 | 2019 | 3424 | 0.090 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2005 | 370 | 0.090 |
Why?
|
| Beverages | 4 | 2010 | 821 | 0.090 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 990 | 0.090 |
Why?
|
| Oxidative Stress | 6 | 2012 | 3113 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2015 | 999 | 0.090 |
Why?
|
| Survival Rate | 9 | 2020 | 12725 | 0.090 |
Why?
|
| Insulin | 6 | 2019 | 6596 | 0.090 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2009 | 350 | 0.090 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2010 | 102 | 0.090 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2011 | 113 | 0.090 |
Why?
|
| Kuwait | 2 | 2021 | 92 | 0.090 |
Why?
|
| Peripheral Arterial Disease | 2 | 2011 | 1273 | 0.090 |
Why?
|
| Coronary Artery Bypass | 4 | 2015 | 2188 | 0.080 |
Why?
|
| RNA-Binding Proteins | 2 | 2016 | 1897 | 0.080 |
Why?
|
| Penetrance | 2 | 2015 | 383 | 0.080 |
Why?
|
| Receptors, Somatostatin | 1 | 2010 | 136 | 0.080 |
Why?
|
| Patient Satisfaction | 3 | 2013 | 3461 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 3 | 2020 | 582 | 0.080 |
Why?
|
| Financing, Organized | 2 | 2008 | 204 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2010 | 192 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 208 | 0.080 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2010 | 141 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 269 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2019 | 1936 | 0.080 |
Why?
|
| Mass Screening | 5 | 2019 | 5428 | 0.080 |
Why?
|
| Peptide Fragments | 2 | 2020 | 5112 | 0.080 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1991 | 273 | 0.080 |
Why?
|
| Morbidity | 4 | 2019 | 1750 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2018 | 1545 | 0.080 |
Why?
|
| Type A Personality | 2 | 2001 | 24 | 0.080 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 565 | 0.080 |
Why?
|
| Receptors, LHRH | 1 | 2009 | 158 | 0.080 |
Why?
|
| Proinsulin | 2 | 2013 | 135 | 0.080 |
Why?
|
| Genome, Mitochondrial | 1 | 2009 | 66 | 0.080 |
Why?
|
| Sample Size | 2 | 2022 | 841 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 1155 | 0.080 |
Why?
|
| Streptokinase | 3 | 2000 | 186 | 0.080 |
Why?
|
| Potassium, Dietary | 1 | 2009 | 103 | 0.080 |
Why?
|
| Thrombophilia | 2 | 2010 | 305 | 0.080 |
Why?
|
| Lipase | 1 | 2011 | 325 | 0.080 |
Why?
|
| Causality | 3 | 2021 | 1242 | 0.080 |
Why?
|
| Glucuronosyltransferase | 1 | 2009 | 132 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 3204 | 0.080 |
Why?
|
| Students, Public Health | 1 | 2008 | 6 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2009 | 287 | 0.080 |
Why?
|
| Hypertension, Renal | 1 | 2008 | 135 | 0.080 |
Why?
|
| 3' Untranslated Regions | 2 | 2007 | 519 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2010 | 339 | 0.080 |
Why?
|
| Apolipoproteins A | 1 | 2008 | 95 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2014 | 1509 | 0.080 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2008 | 224 | 0.080 |
Why?
|
| Poultry | 1 | 2008 | 80 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1779 | 0.070 |
Why?
|
| Activated Protein C Resistance | 1 | 2007 | 18 | 0.070 |
Why?
|
| Resistin | 1 | 2008 | 172 | 0.070 |
Why?
|
| TRPM Cation Channels | 1 | 2009 | 139 | 0.070 |
Why?
|
| Myocardial Ischemia | 5 | 2015 | 2113 | 0.070 |
Why?
|
| Education, Professional | 1 | 2008 | 52 | 0.070 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2007 | 99 | 0.070 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2007 | 17 | 0.070 |
Why?
|
| Muscles | 2 | 2023 | 1576 | 0.070 |
Why?
|
| Dietary Carbohydrates | 2 | 2003 | 891 | 0.070 |
Why?
|
| Chronic Disease | 8 | 2020 | 9318 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2007 | 68 | 0.070 |
Why?
|
| Brain Neoplasms | 3 | 2015 | 9031 | 0.070 |
Why?
|
| Renal Insufficiency | 2 | 2005 | 809 | 0.070 |
Why?
|
| Bone Density Conservation Agents | 1 | 2015 | 795 | 0.070 |
Why?
|
| Health | 1 | 2010 | 398 | 0.070 |
Why?
|
| DNA | 3 | 2010 | 7212 | 0.070 |
Why?
|
| Life Expectancy | 1 | 2014 | 1242 | 0.070 |
Why?
|
| Cocarcinogenesis | 1 | 2007 | 49 | 0.070 |
Why?
|
| Longevity | 2 | 2021 | 1065 | 0.070 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1991 | 748 | 0.070 |
Why?
|
| Postural Balance | 1 | 2012 | 622 | 0.070 |
Why?
|
| Ethics, Medical | 1 | 1992 | 783 | 0.070 |
Why?
|
| Manipulation, Chiropractic | 1 | 2007 | 24 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2012 | 2341 | 0.070 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1990 | 537 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2017 | 4003 | 0.070 |
Why?
|
| Prothrombin | 1 | 2007 | 191 | 0.070 |
Why?
|
| Food Handling | 1 | 2007 | 154 | 0.070 |
Why?
|
| Protein Precursors | 2 | 2009 | 1132 | 0.070 |
Why?
|
| Sensitivity and Specificity | 8 | 2019 | 14666 | 0.070 |
Why?
|
| Forms and Records Control | 1 | 2007 | 158 | 0.070 |
Why?
|
| Massage | 1 | 2007 | 86 | 0.070 |
Why?
|
| Nutrition Assessment | 2 | 2008 | 728 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 916 | 0.070 |
Why?
|
| Malus | 2 | 2005 | 50 | 0.070 |
Why?
|
| Pregnancy | 10 | 2024 | 29874 | 0.070 |
Why?
|
| Aromatase | 1 | 2007 | 147 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2010 | 498 | 0.070 |
Why?
|
| Self Disclosure | 2 | 2000 | 249 | 0.070 |
Why?
|
| Interleukin-18 | 1 | 2008 | 250 | 0.070 |
Why?
|
| Emotions | 1 | 2018 | 2739 | 0.070 |
Why?
|
| Sweden | 3 | 2014 | 1379 | 0.070 |
Why?
|
| Pilot Projects | 7 | 2016 | 8631 | 0.070 |
Why?
|
| Self Medication | 3 | 2006 | 117 | 0.070 |
Why?
|
| Mutation | 5 | 2020 | 30052 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 656 | 0.070 |
Why?
|
| Retrospective Studies | 15 | 2019 | 80636 | 0.070 |
Why?
|
| International Classification of Diseases | 2 | 2009 | 909 | 0.070 |
Why?
|
| Tryptophan | 2 | 2019 | 482 | 0.070 |
Why?
|
| Peptic Ulcer | 1 | 2007 | 217 | 0.070 |
Why?
|
| Angina Pectoris | 4 | 1997 | 959 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2016 | 2180 | 0.070 |
Why?
|
| Pelvic Pain | 1 | 2008 | 298 | 0.070 |
Why?
|
| Age of Onset | 2 | 2010 | 3305 | 0.070 |
Why?
|
| Nootropic Agents | 1 | 2007 | 157 | 0.070 |
Why?
|
| Lactose | 1 | 2006 | 95 | 0.070 |
Why?
|
| Social Class | 2 | 2012 | 2004 | 0.070 |
Why?
|
| Parathyroid Hormone | 2 | 2023 | 1803 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 901 | 0.060 |
Why?
|
| Introns | 3 | 2017 | 981 | 0.060 |
Why?
|
| Immunity | 1 | 2012 | 996 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 299 | 0.060 |
Why?
|
| Dipeptides | 1 | 2007 | 391 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 368 | 0.060 |
Why?
|
| Acute Disease | 6 | 2016 | 7237 | 0.060 |
Why?
|
| Sampling Studies | 1 | 1987 | 615 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 2422 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2243 | 0.060 |
Why?
|
| Cerebral Arteries | 2 | 2005 | 490 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 539 | 0.060 |
Why?
|
| Gene Regulatory Networks | 3 | 2021 | 1745 | 0.060 |
Why?
|
| Blood Platelets | 1 | 1996 | 2479 | 0.060 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 15842 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 5 | 2021 | 2223 | 0.060 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 1502 | 0.060 |
Why?
|
| Maternal Age | 2 | 2019 | 809 | 0.060 |
Why?
|
| Cysteine | 1 | 2010 | 891 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2012 | 1273 | 0.060 |
Why?
|
| Massachusetts | 6 | 2008 | 8830 | 0.060 |
Why?
|
| Models, Statistical | 3 | 2019 | 5079 | 0.060 |
Why?
|
| Hospitalization | 3 | 2022 | 10723 | 0.060 |
Why?
|
| Models, Genetic | 4 | 2018 | 3442 | 0.060 |
Why?
|
| Professional Competence | 1 | 2008 | 431 | 0.060 |
Why?
|
| Femur Neck | 2 | 2020 | 314 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 2917 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2010 | 1154 | 0.060 |
Why?
|
| Education, Medical | 1 | 2016 | 1725 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2009 | 1494 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2010 | 1555 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2011 | 2448 | 0.060 |
Why?
|
| ROC Curve | 4 | 2018 | 3579 | 0.060 |
Why?
|
| Signal Transduction | 6 | 2021 | 23445 | 0.060 |
Why?
|
| Beer | 2 | 2008 | 134 | 0.060 |
Why?
|
| Pain Measurement | 3 | 2009 | 3550 | 0.060 |
Why?
|
| Acetaminophen | 3 | 2005 | 554 | 0.060 |
Why?
|
| Pneumonia | 1 | 2016 | 2143 | 0.060 |
Why?
|
| Neutropenia | 1 | 2009 | 885 | 0.060 |
Why?
|
| Genomic Imprinting | 2 | 2017 | 329 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2005 | 370 | 0.060 |
Why?
|
| Wine | 2 | 2008 | 166 | 0.060 |
Why?
|
| Allergens | 1 | 2011 | 1432 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 795 | 0.060 |
Why?
|
| Brassica | 1 | 2003 | 39 | 0.060 |
Why?
|
| Sleep | 1 | 2019 | 4768 | 0.060 |
Why?
|
| Receptors, Adiponectin | 1 | 2023 | 81 | 0.050 |
Why?
|
| Genes, X-Linked | 2 | 2015 | 128 | 0.050 |
Why?
|
| Molecular Weight | 2 | 2020 | 2186 | 0.050 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2009 | 1148 | 0.050 |
Why?
|
| Dietary Proteins | 1 | 2008 | 952 | 0.050 |
Why?
|
| Sweetening Agents | 2 | 2010 | 290 | 0.050 |
Why?
|
| Computational Biology | 4 | 2018 | 3518 | 0.050 |
Why?
|
| Pain | 3 | 2023 | 5073 | 0.050 |
Why?
|
| Postprandial Period | 2 | 2020 | 315 | 0.050 |
Why?
|
| Patient Participation | 2 | 2007 | 1444 | 0.050 |
Why?
|
| Personnel, Hospital | 1 | 1985 | 285 | 0.050 |
Why?
|
| Awareness | 1 | 2007 | 648 | 0.050 |
Why?
|
| Child | 12 | 2024 | 80153 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2016 | 6484 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 957 | 0.050 |
Why?
|
| Statistics, Nonparametric | 5 | 2009 | 2850 | 0.050 |
Why?
|
| Energy Metabolism | 3 | 2015 | 2882 | 0.050 |
Why?
|
| Kidney | 4 | 2019 | 7048 | 0.050 |
Why?
|
| Hypersensitivity | 1 | 2011 | 1171 | 0.050 |
Why?
|
| Adipose Tissue | 3 | 2003 | 3312 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 3201 | 0.050 |
Why?
|
| Birth Weight | 1 | 2010 | 2103 | 0.050 |
Why?
|
| Calcifediol | 1 | 2023 | 161 | 0.050 |
Why?
|
| Thrombosis | 3 | 2007 | 2942 | 0.050 |
Why?
|
| P-Selectin | 2 | 2002 | 597 | 0.050 |
Why?
|
| Selection Bias | 2 | 2006 | 359 | 0.050 |
Why?
|
| Hysterectomy | 2 | 2020 | 857 | 0.050 |
Why?
|
| Self Care | 1 | 2007 | 796 | 0.050 |
Why?
|
| Genetic Pleiotropy | 1 | 2022 | 181 | 0.050 |
Why?
|
| Cyclin T | 1 | 2021 | 19 | 0.050 |
Why?
|
| Creatinine | 5 | 2006 | 1899 | 0.050 |
Why?
|
| Dyslipidemias | 2 | 2005 | 868 | 0.050 |
Why?
|
| Adipokines | 1 | 2023 | 310 | 0.050 |
Why?
|
| GATA5 Transcription Factor | 1 | 2020 | 18 | 0.050 |
Why?
|
| Apolipoprotein C-III | 1 | 2022 | 211 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2013 | 2321 | 0.050 |
Why?
|
| Phospholipase C beta | 1 | 2020 | 49 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 1069 | 0.050 |
Why?
|
| Body Constitution | 1 | 2001 | 273 | 0.050 |
Why?
|
| France | 2 | 2012 | 497 | 0.050 |
Why?
|
| Common Cold | 1 | 2001 | 63 | 0.050 |
Why?
|
| Likelihood Functions | 2 | 2003 | 992 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 116 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2005 | 1416 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2012 | 2521 | 0.040 |
Why?
|
| Population Groups | 1 | 2021 | 208 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2011 | 1909 | 0.040 |
Why?
|
| Reference Values | 4 | 2011 | 4920 | 0.040 |
Why?
|
| Silicones | 1 | 2001 | 228 | 0.040 |
Why?
|
| Animals | 14 | 2021 | 168459 | 0.040 |
Why?
|
| Parents | 1 | 2014 | 3563 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1809 | 0.040 |
Why?
|
| Abdomen | 2 | 2003 | 1128 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2013 | 297 | 0.040 |
Why?
|
| Population Surveillance | 2 | 2010 | 2598 | 0.040 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2007 | 1085 | 0.040 |
Why?
|
| Blood Glucose | 6 | 2019 | 6391 | 0.040 |
Why?
|
| Teaching | 1 | 2008 | 1170 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 17 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2019 | 2093 | 0.040 |
Why?
|
| Cooperative Behavior | 3 | 2013 | 1505 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 3810 | 0.040 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2019 | 49 | 0.040 |
Why?
|
| Chlamydophila pneumoniae | 1 | 1999 | 53 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2001 | 522 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2001 | 504 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2001 | 343 | 0.040 |
Why?
|
| Neopterin | 1 | 2019 | 56 | 0.040 |
Why?
|
| Public Health | 1 | 2013 | 2669 | 0.040 |
Why?
|
| Pyridoxic Acid | 1 | 2019 | 4 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2010 | 774 | 0.040 |
Why?
|
| Menorrhagia | 1 | 2019 | 59 | 0.040 |
Why?
|
| Electrocardiography | 4 | 2023 | 6377 | 0.040 |
Why?
|
| Estrone | 2 | 2010 | 234 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2022 | 522 | 0.040 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2019 | 120 | 0.040 |
Why?
|
| Exercise Therapy | 3 | 2012 | 929 | 0.040 |
Why?
|
| Time | 1 | 2001 | 546 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2023 | 602 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2020 | 177 | 0.040 |
Why?
|
| Survival Analysis | 4 | 2007 | 10090 | 0.040 |
Why?
|
| Ampulla of Vater | 1 | 2019 | 149 | 0.040 |
Why?
|
| Leucine | 1 | 2020 | 548 | 0.040 |
Why?
|
| Smoking Cessation | 3 | 2011 | 2056 | 0.040 |
Why?
|
| Quality of Life | 5 | 2016 | 13367 | 0.040 |
Why?
|
| Diabetic Angiopathies | 3 | 2009 | 803 | 0.040 |
Why?
|
| Glucose | 2 | 2008 | 4346 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2020 | 282 | 0.040 |
Why?
|
| Probability | 4 | 2009 | 2477 | 0.040 |
Why?
|
| Marital Status | 1 | 2000 | 426 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 36426 | 0.040 |
Why?
|
| Contraceptive Agents | 1 | 2020 | 144 | 0.040 |
Why?
|
| Operating Rooms | 1 | 1985 | 789 | 0.040 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2020 | 177 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2023 | 868 | 0.040 |
Why?
|
| Genomics | 3 | 2022 | 5821 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2018 | 6845 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2021 | 461 | 0.040 |
Why?
|
| International Agencies | 1 | 2019 | 243 | 0.040 |
Why?
|
| Thrombolytic Therapy | 2 | 2000 | 2064 | 0.040 |
Why?
|
| Demography | 3 | 2012 | 1648 | 0.040 |
Why?
|
| Abortion, Habitual | 1 | 1998 | 61 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2018 | 92 | 0.040 |
Why?
|
| Cholesterol Esters | 1 | 1997 | 74 | 0.040 |
Why?
|
| Psychological Tests | 2 | 2012 | 640 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2018 | 126 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 649 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2023 | 1155 | 0.040 |
Why?
|
| Drug Labeling | 1 | 2000 | 248 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2013 | 3429 | 0.040 |
Why?
|
| Biological Availability | 1 | 2018 | 390 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2010 | 4936 | 0.040 |
Why?
|
| Pancreatitis, Chronic | 1 | 2020 | 289 | 0.040 |
Why?
|
| Patient Dropouts | 2 | 2012 | 412 | 0.040 |
Why?
|
| Nephelometry and Turbidimetry | 2 | 2007 | 91 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2018 | 266 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 1998 | 271 | 0.030 |
Why?
|
| Protein C | 1 | 1997 | 133 | 0.030 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 1858 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 244 | 0.030 |
Why?
|
| DNA Helicases | 2 | 2012 | 851 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2000 | 793 | 0.030 |
Why?
|
| Thromboxanes | 1 | 1996 | 45 | 0.030 |
Why?
|
| Heterozygote | 2 | 2008 | 2787 | 0.030 |
Why?
|
| Family Health | 1 | 2001 | 1257 | 0.030 |
Why?
|
| Disease-Free Survival | 4 | 2014 | 6814 | 0.030 |
Why?
|
| Analgesics | 1 | 2003 | 1070 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 5492 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2019 | 503 | 0.030 |
Why?
|
| Exons | 2 | 2014 | 2391 | 0.030 |
Why?
|
| Uric Acid | 1 | 2022 | 807 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2017 | 1897 | 0.030 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1996 | 144 | 0.030 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2017 | 186 | 0.030 |
Why?
|
| Administration, Oral | 3 | 2006 | 4021 | 0.030 |
Why?
|
| Pyridoxine | 1 | 1996 | 108 | 0.030 |
Why?
|
| Simplexvirus | 1 | 1999 | 803 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2016 | 77 | 0.030 |
Why?
|
| Drug Utilization | 2 | 2000 | 1188 | 0.030 |
Why?
|
| Government Programs | 2 | 2008 | 279 | 0.030 |
Why?
|
| Drinking | 2 | 2015 | 198 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1996 | 862 | 0.030 |
Why?
|
| Endpoint Determination | 2 | 2008 | 590 | 0.030 |
Why?
|
| Nitrates | 1 | 1996 | 263 | 0.030 |
Why?
|
| Kidney Calculi | 1 | 2019 | 463 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 543 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2017 | 492 | 0.030 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2001 | 819 | 0.030 |
Why?
|
| Netherlands | 1 | 2020 | 2221 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 1999 | 756 | 0.030 |
Why?
|
| Epoprostenol | 1 | 1996 | 247 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 1996 | 422 | 0.030 |
Why?
|
| Research | 2 | 1994 | 1982 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 1998 | 429 | 0.030 |
Why?
|
| Periodontal Index | 1 | 2015 | 151 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 3 | 2007 | 2691 | 0.030 |
Why?
|
| Potassium Chloride | 1 | 1995 | 230 | 0.030 |
Why?
|
| Organizational Innovation | 2 | 2008 | 537 | 0.030 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2016 | 217 | 0.030 |
Why?
|
| Albuminuria | 1 | 2018 | 657 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1336 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 1996 | 427 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 58 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 783 | 0.030 |
Why?
|
| Leukocyte Count | 2 | 2009 | 1596 | 0.030 |
Why?
|
| Margarine | 1 | 1994 | 17 | 0.030 |
Why?
|
| Guidelines as Topic | 2 | 2013 | 1386 | 0.030 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 1994 | 144 | 0.030 |
Why?
|
| Patient Discharge | 2 | 1999 | 3443 | 0.030 |
Why?
|
| Fibrinolysis | 1 | 2015 | 332 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 205 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.030 |
Why?
|
| Nurses | 3 | 2010 | 2478 | 0.030 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6228 | 0.030 |
Why?
|
| Hip Fractures | 1 | 2022 | 988 | 0.030 |
Why?
|
| Rad51 Recombinase | 1 | 2014 | 189 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 285 | 0.030 |
Why?
|
| Trace Elements | 1 | 1995 | 195 | 0.030 |
Why?
|
| Movement | 2 | 2012 | 1478 | 0.030 |
Why?
|
| Habits | 1 | 2014 | 147 | 0.030 |
Why?
|
| Trans Fatty Acids | 1 | 2015 | 155 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 550 | 0.030 |
Why?
|
| Blood Proteins | 2 | 2016 | 1173 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 224 | 0.030 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 1 | 2013 | 12 | 0.030 |
Why?
|
| Seasons | 1 | 2019 | 1520 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 1469 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1387 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2015 | 422 | 0.030 |
Why?
|
| Laboratories | 1 | 2017 | 458 | 0.030 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2016 | 276 | 0.030 |
Why?
|
| Rehabilitation | 1 | 2014 | 130 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 509 | 0.030 |
Why?
|
| Diet, Sodium-Restricted | 1 | 1995 | 292 | 0.030 |
Why?
|
| Anger | 1 | 1995 | 406 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 4016 | 0.030 |
Why?
|
| Memory | 2 | 2013 | 2188 | 0.030 |
Why?
|
| Melanesia | 1 | 2012 | 13 | 0.030 |
Why?
|
| Amides | 1 | 2015 | 449 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2015 | 2571 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3802 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 1988 | 7407 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2012 | 80 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 70 | 0.030 |
Why?
|
| Epinephrine | 1 | 1996 | 792 | 0.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2011 | 1725 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 926 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 1722 | 0.020 |
Why?
|
| Celiac Disease | 1 | 2020 | 821 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2016 | 517 | 0.020 |
Why?
|
| DNA Copy Number Variations | 2 | 2011 | 2020 | 0.020 |
Why?
|
| Lipoproteins, VLDL | 2 | 2010 | 201 | 0.020 |
Why?
|
| Lod Score | 1 | 2012 | 600 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 1999 | 2696 | 0.020 |
Why?
|
| Weight Loss | 2 | 2012 | 2684 | 0.020 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 11121 | 0.020 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2016 | 478 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2020 | 1394 | 0.020 |
Why?
|
| Survivors | 1 | 2022 | 2371 | 0.020 |
Why?
|
| Copying Processes | 1 | 1991 | 5 | 0.020 |
Why?
|
| Drug Costs | 1 | 2000 | 1183 | 0.020 |
Why?
|
| International Cooperation | 1 | 2018 | 1422 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 110 | 0.020 |
Why?
|
| Glycosylation | 1 | 2014 | 1098 | 0.020 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2011 | 103 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2001 | 4544 | 0.020 |
Why?
|
| Sulfinpyrazone | 1 | 1990 | 15 | 0.020 |
Why?
|
| DNA Methylation | 2 | 2016 | 4398 | 0.020 |
Why?
|
| Patch Tests | 1 | 1991 | 57 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 1996 | 983 | 0.020 |
Why?
|
| Memory Disorders | 2 | 2009 | 1198 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1996 | 1241 | 0.020 |
Why?
|
| C-Peptide | 1 | 2012 | 440 | 0.020 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 2416 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 413 | 0.020 |
Why?
|
| Base Sequence | 3 | 2012 | 12441 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2021 | 2568 | 0.020 |
Why?
|
| Aminoglycosides | 2 | 1988 | 160 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2018 | 1139 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 192 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2960 | 0.020 |
Why?
|
| Dipyridamole | 1 | 1990 | 140 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2016 | 785 | 0.020 |
Why?
|
| Lipoproteins, IDL | 1 | 2010 | 18 | 0.020 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2010 | 72 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 701 | 0.020 |
Why?
|
| Osteoarthritis, Knee | 1 | 2020 | 1234 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 4352 | 0.020 |
Why?
|
| Somatomedins | 1 | 2010 | 179 | 0.020 |
Why?
|
| Glycosyltransferases | 1 | 2010 | 117 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2010 | 125 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 346 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 1600 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1996 | 1516 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2003 | 2781 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 1738 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 430 | 0.020 |
Why?
|
| Bronchitis, Chronic | 1 | 2010 | 82 | 0.020 |
Why?
|
| Symporters | 1 | 2012 | 363 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2015 | 897 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 3847 | 0.020 |
Why?
|
| Puberty, Delayed | 1 | 2010 | 121 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2011 | 311 | 0.020 |
Why?
|
| United Arab Emirates | 1 | 2009 | 42 | 0.020 |
Why?
|
| Geography | 1 | 2011 | 656 | 0.020 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1992 | 488 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2010 | 156 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1995 | 2571 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 799 | 0.020 |
Why?
|
| Melanoma | 3 | 2021 | 5709 | 0.020 |
Why?
|
| Interleukin-9 | 1 | 2009 | 62 | 0.020 |
Why?
|
| Leisure Activities | 1 | 2011 | 308 | 0.020 |
Why?
|
| Hypogonadism | 1 | 2015 | 798 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.020 |
Why?
|
| Puberty, Precocious | 1 | 2010 | 164 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 1541 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 1787 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 1035 | 0.020 |
Why?
|
| Hyperacusis | 1 | 2009 | 31 | 0.020 |
Why?
|
| Premature Birth | 1 | 2021 | 1782 | 0.020 |
Why?
|
| Coronary Thrombosis | 1 | 1991 | 440 | 0.020 |
Why?
|
| Glioblastoma | 2 | 2015 | 3482 | 0.020 |
Why?
|
| Denmark | 1 | 1991 | 771 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 489 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2010 | 341 | 0.020 |
Why?
|
| Photophobia | 1 | 2009 | 75 | 0.020 |
Why?
|
| Femur | 1 | 2015 | 1307 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 825 | 0.020 |
Why?
|
| Health Services Research | 1 | 1996 | 1812 | 0.020 |
Why?
|
| Social Support | 1 | 2018 | 2171 | 0.020 |
Why?
|
| Hyperhomocysteinemia | 1 | 2008 | 118 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2009 | 215 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1999 | 3156 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1996 | 3514 | 0.020 |
Why?
|
| Rheumatoid Factor | 1 | 2008 | 185 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 1922 | 0.020 |
Why?
|
| Hip Joint | 1 | 2015 | 1014 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 350 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2009 | 7390 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 6019 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2009 | 367 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2008 | 153 | 0.020 |
Why?
|
| Androstenedione | 1 | 2007 | 131 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 7581 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2012 | 7045 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 1991 | 659 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2020 | 2279 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2009 | 245 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 832 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2021 | 6240 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2010 | 532 | 0.020 |
Why?
|
| Cytokines | 1 | 2002 | 7396 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2011 | 620 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 829 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 1990 | 999 | 0.020 |
Why?
|
| Apoprotein(a) | 1 | 2006 | 17 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2021 | 26198 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2018 | 2986 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2014 | 3968 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 1567 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2831 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 1217 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2013 | 1420 | 0.020 |
Why?
|
| Urinalysis | 1 | 2009 | 368 | 0.020 |
Why?
|
| Dehydroepiandrosterone | 1 | 2007 | 258 | 0.020 |
Why?
|
| Efficiency | 1 | 1990 | 476 | 0.020 |
Why?
|
| China | 1 | 2012 | 2369 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2001 | 363 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4124 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2007 | 238 | 0.020 |
Why?
|
| Calibration | 1 | 2009 | 818 | 0.020 |
Why?
|
| Progesterone | 2 | 2001 | 742 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 13639 | 0.020 |
Why?
|
| Decision Making | 2 | 2007 | 3929 | 0.020 |
Why?
|
| Algorithms | 1 | 2007 | 14031 | 0.020 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2010 | 376 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 1992 | 1444 | 0.020 |
Why?
|
| Hospital Records | 1 | 1986 | 93 | 0.020 |
Why?
|
| Cerebellum | 1 | 2013 | 1501 | 0.020 |
Why?
|
| Death | 1 | 2010 | 676 | 0.020 |
Why?
|
| Nausea | 1 | 2009 | 679 | 0.020 |
Why?
|
| Evidence-Based Medicine | 2 | 2008 | 3688 | 0.020 |
Why?
|
| Posture | 1 | 2010 | 957 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 784 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 1091 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1405 | 0.020 |
Why?
|
| Vomiting | 1 | 2009 | 651 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 629 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3270 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2009 | 1572 | 0.020 |
Why?
|
| Prostatic Hyperplasia | 1 | 2009 | 521 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 2010 | 684 | 0.020 |
Why?
|
| Women, Working | 1 | 2005 | 86 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2009 | 633 | 0.020 |
Why?
|
| New England | 1 | 2008 | 1054 | 0.020 |
Why?
|
| Milk | 1 | 2007 | 443 | 0.010 |
Why?
|
| Albumins | 1 | 2007 | 575 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2006 | 437 | 0.010 |
Why?
|
| Particle Size | 1 | 2009 | 1648 | 0.010 |
Why?
|
| Tobacco Use Disorder | 1 | 2010 | 703 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3778 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 1998 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1987 | 667 | 0.010 |
Why?
|
| Gait | 1 | 2010 | 814 | 0.010 |
Why?
|
| Central Nervous System Depressants | 1 | 2005 | 164 | 0.010 |
Why?
|
| Pedigree | 1 | 2012 | 4542 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2007 | 368 | 0.010 |
Why?
|
| Glycine | 1 | 2007 | 663 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16981 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1640 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1990 | 1668 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 81525 | 0.010 |
Why?
|
| Arginine | 1 | 2007 | 934 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 3448 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 865 | 0.010 |
Why?
|
| Medicare | 1 | 2022 | 6770 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4740 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1776 | 0.010 |
Why?
|
| Mental Health | 1 | 2018 | 3250 | 0.010 |
Why?
|
| Confidentiality | 1 | 2007 | 609 | 0.010 |
Why?
|
| Internationality | 1 | 2009 | 1001 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8654 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4414 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2015 | 4471 | 0.010 |
Why?
|
| Lysine | 1 | 2007 | 993 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 1702 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22169 | 0.010 |
Why?
|
| Edetic Acid | 1 | 2003 | 280 | 0.010 |
Why?
|
| Immunoassay | 1 | 2006 | 745 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1961 | 0.010 |
Why?
|
| Air Pollutants, Occupational | 1 | 1985 | 407 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3849 | 0.010 |
Why?
|
| Health Occupations | 1 | 2003 | 222 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1699 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2003 | 678 | 0.010 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2001 | 106 | 0.010 |
Why?
|
| Schools | 1 | 2010 | 1489 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5247 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2006 | 970 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2009 | 1356 | 0.010 |
Why?
|
| Complement C4 | 1 | 2001 | 217 | 0.010 |
Why?
|
| Vena Cava, Inferior | 1 | 1984 | 458 | 0.010 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2002 | 198 | 0.010 |
Why?
|
| Cyclamates | 1 | 1980 | 1 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2001 | 284 | 0.010 |
Why?
|
| Saccharin | 1 | 1980 | 20 | 0.010 |
Why?
|
| Serum Amyloid A Protein | 1 | 2000 | 127 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1985 | 709 | 0.010 |
Why?
|
| E-Selectin | 1 | 2002 | 576 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2001 | 397 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 1985 | 533 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4111 | 0.010 |
Why?
|
| Complement C3 | 1 | 2001 | 435 | 0.010 |
Why?
|
| Anesthetics | 1 | 1985 | 523 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 2001 | 355 | 0.010 |
Why?
|
| Psychometrics | 1 | 2008 | 3065 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1990 | 2576 | 0.010 |
Why?
|
| Keratins | 1 | 2000 | 498 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2007 | 2547 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 2078 | 0.010 |
Why?
|
| Brain | 1 | 2005 | 27112 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2007 | 2025 | 0.010 |
Why?
|
| HIV-1 | 1 | 1995 | 6863 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 2001 | 978 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12795 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2000 | 15631 | 0.010 |
Why?
|
| Lung | 1 | 2016 | 10000 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 2897 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2010 | 2751 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 1341 | 0.010 |
Why?
|
| Heparin | 1 | 1984 | 1634 | 0.010 |
Why?
|
| Liver Diseases | 1 | 1985 | 1298 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2001 | 1527 | 0.010 |
Why?
|
| Urologic Neoplasms | 1 | 1980 | 314 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 5789 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2003 | 1835 | 0.010 |
Why?
|
| Vitamin A Deficiency | 1 | 1995 | 88 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1978 | 379 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2008 | 3537 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1995 | 329 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 1992 | 5440 | 0.010 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 1995 | 118 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2007 | 3242 | 0.010 |
Why?
|
| Methylation | 1 | 1996 | 1084 | 0.010 |
Why?
|
| Intestinal Polyps | 1 | 1993 | 104 | 0.010 |
Why?
|
| Point Mutation | 1 | 1998 | 1595 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 1992 | 7879 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2007 | 7967 | 0.010 |
Why?
|
| England | 2 | 1984 | 526 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20570 | 0.010 |
Why?
|
| Zinc | 1 | 1995 | 690 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1995 | 755 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2003 | 2471 | 0.010 |
Why?
|
| Lymphoma | 1 | 1999 | 1901 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1991 | 685 | 0.010 |
Why?
|
| HIV Infections | 1 | 1995 | 17351 | 0.000 |
Why?
|
| Japan | 2 | 1984 | 1378 | 0.000 |
Why?
|
| Arteriosclerosis | 1 | 1992 | 1055 | 0.000 |
Why?
|
| Adjuvants, Immunologic | 1 | 1993 | 1036 | 0.000 |
Why?
|
| Death, Sudden | 1 | 1989 | 301 | 0.000 |
Why?
|
| Sisomicin | 1 | 1986 | 5 | 0.000 |
Why?
|
| Netilmicin | 1 | 1986 | 8 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 550 | 0.000 |
Why?
|
| Amikacin | 1 | 1986 | 47 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1991 | 1687 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 5796 | 0.000 |
Why?
|
| Tobramycin | 1 | 1986 | 65 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1741 | 0.000 |
Why?
|
| Gentamicins | 1 | 1986 | 243 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 9177 | 0.000 |
Why?
|
| Surgical Equipment | 1 | 1984 | 57 | 0.000 |
Why?
|
| Autopsy | 1 | 1987 | 1008 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 8529 | 0.000 |
Why?
|
| Public Policy | 1 | 1987 | 559 | 0.000 |
Why?
|
| Hearing | 1 | 1986 | 501 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17635 | 0.000 |
Why?
|
| Biometry | 1 | 1985 | 563 | 0.000 |
Why?
|
| Surgical Mesh | 1 | 1984 | 311 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1989 | 1200 | 0.000 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1987 | 946 | 0.000 |
Why?
|
| Carcinogens | 1 | 1982 | 452 | 0.000 |
Why?
|
| Myocardium | 1 | 1991 | 4726 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1978 | 2915 | 0.000 |
Why?
|
| Infant | 1 | 1978 | 36192 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1978 | 42230 | 0.000 |
Why?
|